Investors are chasing bond yields ahead of the Fed’s rate decision. Here’s the opportunity.
Investors want to lock in income with stocks near all-time highs, but inflation still remains a concern. Source link
Business
Read More
Elon Musk is still top dog, but Oracle’s Larry Ellison is now just $1 billion behind
The Oracle co-founder’s net worth has jumped by nearly $90 billion, but he’s still a hair behind Elon Musk in…
Oxford Industries says new Lilly Pulitzer offerings are winning over shoppers, but its Tommy Bahama line is lagging
Resort-style clothing maker Oxford Industries Inc. on Wednesday offered up mixed second-quarter results and third-quarter expectations, and said that while…
I’m 80 and my RMD is $300,000. What the heck am I supposed to do about my huge tax bill?
A teacher turned $600,000 into $6 million and now has a huge tax bill Source link
CoreWeave’s stock has surged 38% in 4 days. Why investors might be getting ahead of themselves.
The AI play is benefitting from surging cloud-computing demand. But if it wants to stay successful, the company must create…
What many investors are looking for in the August CPI data coming out tomorrow
Investors are looking ahead to an August consumer-price index report on Thursday that has the potential to curb the Federal…
Don’t let Apple’s stock dip fool you. The iPhone 17 could power a big rally.
Melius Research analyst Ben Reitzes believes Apple’s stock could reach $290, boosted by increased revenues from its new iPhones. Source…
It’s been on and off the market, but the Baldwins are keeping their Hamptons estate
Despite making multiple attempts to sell it, Alec and Hilaria Baldwin say they have no plans to part ways with…
‘He is increasingly angry’: My troubled son lives with me. How do I ensure he is financially secure after I die?
“Our family does have a long history of interventions, including hospitalizations.” Source link
Weight-loss drug manufacturer Novo Nordisk cuts 9000 jobs — and its profit forecast
New CEO Mike Doustdar is kitchen-sinking the costs of restructuring the company to focus on diabetes and anti-obesity drugs. Source…